Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Thrombosis
•
Pediatric Hematology
•
Anticoagulation
•
Pediatric Oncology
If a pediatric patient has a prior history of cancer-associated thrombosis while receiving active treatment, can they be on estrogen-containing OCPs in the future?
Related Questions
Do you recommend indefinite anticoagulation for patients with homozygous Factor V Leiden mutation who have had a provoked VTE?
What are your top takeaways from ISTH 2025?
What is your standard diagnostic workup to confirm GVHD in a patient post-BMT with skin rash and jaundice?
How would you counsel a woman with a strong family history of thrombosis about oral contraceptives?
How would you manage moderate eosinophilia (~2-3k) with no evidence of end organ damage?
How do you counsel an otherwise healthy patient on how soon they can go back to moderate exercise after a bilateral pulmonary embolism?
What are your top takeaways in Hematologic Malignancies from ASH 2025?
How would you manage a rare presentation of an older adult after gross total resection of an "infant-type hemispheric glioma" of the left frontal lobe, IDH1 negative and negative for MYB fusions?
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
What are the main barriers you encounter in enrolling pediatric oncology patients on clinical trials?
